163
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Association Between Serum Total Bilirubin and COPD: Results from a Cross-Sectional Study and a Bidirectional Mendelian Randomization Analysis

ORCID Icon, , , , , ORCID Icon, ORCID Icon, ORCID Icon, , , ORCID Icon, ORCID Icon, & show all
Pages 289-298 | Published online: 10 Mar 2022

References

  • Agusti A, Vogelmeier C, Papi A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease. Am J Respir Critical Care Med. 2021;5:557–558.
  • Blasi F, Cesana G, Conti S, et al. The clinical and economic impact of exacerbations of chronic obstructive pulmonary disease: a cohort of hospitalized patients. PLoS One. 2014;9(6):e101228. doi:10.1371/journal.pone.0101228
  • Roggeri A, Micheletto C, Roggeri DP. Outcomes and costs of treating chronic obstructive pulmonary disease with inhaled fixed combinations: the Italian perspective of the PATHOS study. Int J Chron Obstruct Pulmon Dis. 2014;9:569–576. doi:10.2147/COPD.S65693
  • Stocker R, Yamamoto Y, Mcdonagh A, Glazer A, Ames B. Bilirubin is an antioxidant of possible physiological importance. Science. 1987;235:43. doi:10.1126/science.3029864
  • Lin JP, Vitek L, Schwertner HA. Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease. Clin Chem. 2010;56(10):1535–1543. doi:10.1373/clinchem.2010.151043
  • Schwertner HA, Vitek L. Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis. 2008;198(1):1–11. doi:10.1016/j.atherosclerosis.2008.01.001
  • Wei J, Zhao H, Fan G, Li J. Bilirubin treatment suppresses pulmonary inflammation in a rat model of smoke-induced emphysema. Biochem Biophys Res Commun. 2015;465(2):180–187. doi:10.1016/j.bbrc.2015.07.133
  • Apperley S, Park HY, Holmes DT, et al. Serum bilirubin and disease progression in mild COPD. Chest. 2015;148(1):169–175. doi:10.1378/chest.14-2150
  • Brown KE, Sin DD, Voelker H, et al. Serum bilirubin and the risk of chronic obstructive pulmonary disease exacerbations. Respir Res. 2017;18(1):179. doi:10.1186/s12931-017-0664-0
  • Curjuric I, Imboden M, Adam M, et al. Serum bilirubin is associated with lung function in a Swiss general population sample. Eur Respir J. 2014;43(5):1278–1288. doi:10.1183/09031936.00055813
  • Leem AY, Kim HY, Kim YS, Park MS, Chang J, Jung JY. Association of serum bilirubin level with lung function decline: a Korean community-based cohort study. Respir Res. 2018;19(1):99. doi:10.1186/s12931-018-0814-z
  • Leem AY, Kim YS, Lee JH, et al. Serum bilirubin level is associated with exercise capacity and quality of life in chronic obstructive pulmonary disease. Respir Res. 2019;20(1):279. doi:10.1186/s12931-019-1241-5
  • MacDonald DM, Zanotto AD, Collins G, et al. Associations between baseline biomarkers and lung function in HIV-positive individuals. AIDS. 2019;33(4):655–664. doi:10.1097/QAD.0000000000002101
  • MacDonald DM, Kunisaki KM, Wilt TJ, Baldomero AK. Serum bilirubin and chronic obstructive pulmonary disease (COPD): a systematic review. BMC Pulm Med. 2021;21(1):33. doi:10.1186/s12890-021-01395-9
  • Duzenli T, Maden O, Tanoglu A, Kaplan M, Yazgan Y. Associations between Gilbert’s syndrome and personality characteristics. Trends Psychiatry Psychother. 2021;43(2):151–158. doi:10.47626/2237-6089-2020-0003
  • Miller MR, Crapo R, Hankinson J, et al. General considerations for lung function testing. Eur Respir J. 2005;26(1):153–161. doi:10.1183/09031936.05.00034505
  • Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805
  • Aarsand AK, Diaz-Garzon J, Fernandez-Calle P, et al. The EuBIVAS: within- and between-subject biological variation data for electrolytes, lipids, urea, uric acid, total protein, total bilirubin, direct bilirubin, and glucose. Clin Chem. 2018;64(9):1380–1393. doi:10.1373/clinchem.2018.288415
  • Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med. 2007;176(8):753–760. doi:10.1164/rccm.200612-1749OC
  • Buist AS, Vollmer W, Sullivan S, et al. The burden of obstructive lung disease initiative (BOLD): rationale and design. COPD. 2005;2(2):277–283. doi:10.1081/COPD-57610
  • Shrine N, Guyatt AL, Erzurumluoglu AM, et al. New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries. Nat Genet. 2019;51(3):481–493. doi:10.1038/s41588-018-0321-7
  • Codd V, Nelson CP, Albrecht E, et al. Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet. 2013;45(4):422–427, 427e421–422. doi:10.1038/ng.2528
  • Au Yeung SL, Borges MC, Lawlor DA. Association of genetic instrumental variables for lung function on coronary artery disease risk: a 2-Sample Mendelian Randomization Study. Circ Genom Precis Med. 2018;11(4):e001952. doi:10.1161/CIRCGEN.117.001952
  • Hemani G, Zheng J, Elsworth B, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7. doi:10.7554/eLife.34408
  • McCarty MF. “Iatrogenic Gilbert syndrome”–a strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin. Med Hypotheses. 2007;69(5):974–994. doi:10.1016/j.mehy.2006.12.069
  • Horsfall LJ, Rait G, Walters K, et al. Serum bilirubin and risk of respiratory disease and death. JAMA. 2011;305:691–697. doi:10.1001/jama.2011.124
  • Gazzin S, Vitek L, Watchko J, Shapiro SM, Tiribelli C, Novel A. Perspective on the biology of bilirubin in health and disease. Trends Mol Med. 2016;22(9):758–768. doi:10.1016/j.molmed.2016.07.004
  • Wagner KH, Wallner M, Molzer C, et al. Looking to the horizon: the role of bilirubin in the development and prevention of age-related chronic diseases. Clin Sci (Lond). 2015;129(1):1–25. doi:10.1042/CS20140566
  • Vitek L, Bellarosa C, Tiribelli C. Induction of mild hyperbilirubinemia: hype or real therapeutic opportunity? Clin Pharmacol Ther. 2019;106(3):568–575. doi:10.1002/cpt.1341
  • Ryter SW, Morse D, Choi AM. Carbon monoxide and bilirubin: potential therapies for pulmonary/vascular injury and disease. Am J Respir Cell Mol Biol. 2007;36(2):175–182. doi:10.1165/rcmb.2006-0333TR
  • Kirkham PA, Barnes PJ. Oxidative stress in COPD. Chest. 2013;144(1):266–273. doi:10.1378/chest.12-2664
  • Harijith A, Natarajan V, Fu P. The role of nicotinamide adenine dinucleotide phosphate oxidases in lung architecture remodeling. Antioxidants. 2017;6(4). doi:10.3390/antiox6040104
  • O’Malley SS, Wu R, Mayne ST, Jatlow PI. Smoking cessation is followed by increases in serum bilirubin, an exogenous antioxidant associated with lower risk of lung cancer and cardiovascular disease. Nicotine Tob Res. 2014;16:1145–1149. doi:10.1093/ntr/ntu067
  • Kotal P, Vitek L, Fevery J. Fasting-related hyperbilirubinemia in rats the effect of decreased intestinal motility. Gastroenterology. 1966;111:217–223.
  • Peng H, Li C, Wu X, et al. Association between systemic lupus erythematosus and lung cancer: results from a pool of cohort studies and Mendelian randomization analysis. J Thorac Dis. 2020;12(10):5299–5302. doi:10.21037/jtd-20-2462